About Us
SCINOVA LABS LLP
SCINOVA LABS LLP was established in 2021, under the Govt of India, Ministry of Corporate Affairs, Central Registration Centre, rule 12(1) of the Limited Liability Partnership Act, 2008. The company is recognized by the Startup India. SCINOVA LABS focuses on manufacturing nano-technology-based anti-snake venom ( Nano-ASV) and other materials for experimental models in higher learning. This innovative approach to creating anti-snake venom using nano-technology is fascinating and holds promise for addressing a critical need in the medical and scientific community.
Snake envenomation is one of the important public health hazards in tropical countries affecting farmers, plantation workers, herdsmen, fishermen, etc. Worldwide near about 4.5 million, people suffer from snake bites, out of which 2.7 million suffer various morbidities & about 100,000 die every year. The majority of incidences of deaths and chronic disabilities occur in South and Southeast Asia among active young populations involved in farming and SCINOVA LABSCreang innovave soluons for snake envenomaon plantation occupation due to a lack of health care facilities. India encounters about 35000-50000 deaths annually from snake envenomation.
Nano-ASV is a unique product established through vigorous research and development activities and proven as a strong snake venom inhibitor.
The company wishes to provide affordable nano-ASV to snake bite victims and they must be easily available in the right places.